Enveric Biosciences (ENVB) vs Exicure (XCUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Enveric Biosciences is the larger company by market cap ($6.8 million vs $6.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENVB | XCUR |
|---|---|---|
| Share price | $1.52 | $1.00 |
| Market cap | $6.80M | $6.55M |
| 1-day change | +1.67% | -1.96% |
| EPS (TTM) | $-13.01 | $-1.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.25 | $9.48 |
| 52-week low | $1.17 | $0.99 |
| Distance from 52-week high | -88.53% | -89.45% |
| Average volume | 103.09K | 394.73K |
| Shares outstanding | 4.48M | 6.55M |
| Employees | 5 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Enveric Biosciences
ENVB stock →Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
Healthcare · Biotechnology · 5 employees
About Exicure
XCUR stock →Exicure, Inc. does not have significant operations.
Healthcare · Biotechnology · 1 employees
ENVB vs XCUR FAQ
Which is bigger, Enveric Biosciences or Exicure?
Enveric Biosciences (ENVB) is larger, with a market capitalization of $6.80M compared with $6.55M for Exicure (XCUR).
Are Enveric Biosciences and Exicure in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.